For research use only. Not for therapeutic Use.
Antitubercular agent-30（Cat No.:I041184）is an experimental compound being developed for the treatment of tuberculosis (TB), particularly drug-resistant strains. It targets key enzymes and proteins involved in the survival and replication of Mycobacterium tuberculosis, the bacteria responsible for TB. By inhibiting these critical pathways, Antitubercular agent-30 aims to reduce bacterial load and accelerate the eradication of the infection. Preclinical studies have shown promising efficacy against both drug-sensitive and multidrug-resistant strains of TB. Clinical trials are ongoing to assess its safety, effectiveness, and potential to address the global challenge of TB resistance.
| CAS Number | 384857-54-9 |
| Synonyms | N-(4-nitrophenyl)-2-thiophen-2-ylacetamide |
| Molecular Formula | C12H10N2O3S |
| Purity | ≥95% |
| IUPAC Name | N-(4-nitrophenyl)-2-thiophen-2-ylacetamide |
| InChI | InChI=1S/C12H10N2O3S/c15-12(8-11-2-1-7-18-11)13-9-3-5-10(6-4-9)14(16)17/h1-7H,8H2,(H,13,15) |
| InChIKey | BOASBEGFXYCEPO-UHFFFAOYSA-N |
| SMILES | C1=CSC(=C1)CC(=O)NC2=CC=C(C=C2)[N+](=O)[O-] |
